351 related articles for article (PubMed ID: 31774710)
1. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.
Kahalley LS; Peterson R; Ris MD; Janzen L; Okcu MF; Grosshans DR; Ramaswamy V; Paulino AC; Hodgson D; Mahajan A; Tsang DS; Laperriere N; Whitehead WE; Dauser RC; Taylor MD; Conklin HM; Chintagumpala M; Bouffet E; Mabbott D
J Clin Oncol; 2020 Feb; 38(5):454-461. PubMed ID: 31774710
[TBL] [Abstract][Full Text] [Related]
2. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma.
Eaton BR; Fong GW; Ingerski LM; Pulsifer MB; Goyal S; Zhang C; Weyman EA; Esiashvili N; Klosky JL; MacDonald TJ; Ebb DH; MacDonald SM; Tarbell NJ; Yock TI
Cancer; 2021 Oct; 127(20):3840-3846. PubMed ID: 34255345
[TBL] [Abstract][Full Text] [Related]
3. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
4. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
Pulsifer MB; Duncanson H; Grieco J; Evans C; Tseretopoulos ID; MacDonald S; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):391-398. PubMed ID: 30108004
[TBL] [Abstract][Full Text] [Related]
5. Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
Gross JP; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla RR; Smiley NP; Chang JH; Gondi V
Neuro Oncol; 2019 Jul; 21(7):934-943. PubMed ID: 30997512
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.
Bielamowicz K; Okcu MF; Sonabend R; Paulino AC; Hilsenbeck SG; Dreyer Z; Suzawa H; Bryant R; Adesina A; Dauser R; Mahajan A; Chintagumpala M
Pediatr Hematol Oncol; 2018 May; 35(4):257-267. PubMed ID: 30537887
[TBL] [Abstract][Full Text] [Related]
7. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
8. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.
Kahalley LS; Douglas Ris M; Mahajan A; Fatih Okcu M; Chintagumpala M; Paulino AC; Whitehead WE; Minard CG; Stancel HH; Orobio J; Xue JJ; Warren EA; Grosshans DR
Neuro Oncol; 2019 Jun; 21(6):809-818. PubMed ID: 30753584
[TBL] [Abstract][Full Text] [Related]
9. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.
Kahalley LS; Ris MD; Grosshans DR; Okcu MF; Paulino AC; Chintagumpala M; Moore BD; Guffey D; Minard CG; Stancel HH; Mahajan A
J Clin Oncol; 2016 Apr; 34(10):1043-9. PubMed ID: 26811522
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
[TBL] [Abstract][Full Text] [Related]
11. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
12. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.
Pulsifer MB; Sethi RV; Kuhlthau KA; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):400-7. PubMed ID: 26254679
[TBL] [Abstract][Full Text] [Related]
13. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
14. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy.
Child AE; Warren EA; Grosshans DR; Paulino AC; Okcu MF; Ris MD; Mahajan A; Orobio J; Cirino PT; Minard CG; Viana AG; Bick J; Woods SP; Chintagumpala M; Kahalley LS
Pediatr Blood Cancer; 2021 Sep; 68(9):e29125. PubMed ID: 34114294
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
[TBL] [Abstract][Full Text] [Related]
16. Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
Moxon-Emre I; Taylor MD; Bouffet E; Hardy K; Campen CJ; Malkin D; Hawkins C; Laperriere N; Ramaswamy V; Bartels U; Scantlebury N; Janzen L; Law N; Walsh KS; Mabbott DJ
J Clin Oncol; 2016 Dec; 34(34):4161-4170. PubMed ID: 27507873
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
[TBL] [Abstract][Full Text] [Related]
18. Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961.
Ris MD; Walsh K; Wallace D; Armstrong FD; Holmes E; Gajjar A; Zhou T; Packer RJ
Pediatr Blood Cancer; 2013 Aug; 60(8):1350-7. PubMed ID: 23444345
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.
Yock TI; Bhat S; Szymonifka J; Yeap BY; Delahaye J; Donaldson SS; MacDonald SM; Pulsifer MB; Hill KS; DeLaney TF; Ebb D; Huang M; Tarbell NJ; Fisher PG; Kuhlthau KA
Radiother Oncol; 2014 Oct; 113(1):89-94. PubMed ID: 25304720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
